Constipation in Children with Cerebral Palsy: Prevalence, Clinical Manifestations, and Polyethylene glycol vs. Lactulose Efficacy Constipation with cerebral palsy and polyethylene glycol combination with lactulose
Iranian Journal of Child Neurology,
Vol. 19 No. 3 (2025),
25 June 2025
,
Page 71-76
https://doi.org/10.22037/ijcn.v19i3.45043
Abstract
Objectives
Cerebral palsy (CP) is a neurological disorder causing impaired movement control. Constipation is a common issue among these patients, with the prevalence ranging from 26% to 74%. This study aims to investigate the prevalence of constipation, examine associated symptoms, and compare the effects of commonly used drugs, including Lactulose and Polyethylene Glycol (PEG), in children with CP. These drugs can improve constipation management in this population and prevent serious complications, such as intestinal obstruction and bleeding.
Materials & Methods:
The present research was a prospective cross-sectional study of 48 children and adolescents aged 1 to 15 with CP. According to our definition of constipation based on the ROME IV criteria, the prevalence of constipation in children with CP was calculated. Patients were randomly divided into two groups: Group 1 received treatment with PEG, while Group 2 received treatment with Lactulose. The patients were followed up one month later and then every three months to assess treatment response and monitor clinical symptoms.
Results:
At both 12 and 24 weeks following the initiation of the treatment, a significant increase in the frequency of defecation per week was observed, accompanied by a notable decrease in the frequency of fecal incontinence in both groups. After 24 weeks of treatment, the defecation frequency increased from 1.5 to 6.3 in Group 1 (PEG group) and 1.6 to 5.7 in Group 2 (Lactulose group). Fecal incontinence reduced from initial values of 1.8 and 1.9 to 1.2 and 1.5 in Groups 1 and 2, respectively.
Conclusion:
This study confirms that constipation is a common problem among children with CP. According to the obtained findings, PEG appeared to be more effective than Lactulose in managing constipation in children with CP.
- constipation
- Cerebal palsy
- Polyethylene glycol
- Lactulose
How to Cite
References
Sadowska M, Sarecka-Hujar B, Kopyta I. Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatric disease and treatment. 2020:1505-18.
Dodge NN. Cerebral palsy: medical aspects. Pediatric Clinics of North America. 2008;55(5):1189-207.
Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J, et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA pediatrics. 2017;171(9):897-907.
Reddihough DS, Collins KJ. The epidemiology and causes of cerebral palsy. Australian Journal of physiotherapy. 2003;49(1):7-12.
Awan WA, Masood T. Role of stretching exercises in the management of constipation in spastic cerebral palsy. Journal of Ayub Medical College Abbottabad. 2016;28(4):798-801.
Veugelers R, Benninga MA, Calis EA, Willemsen SP, Evenhuis H, Tibboel D, Penning C. Prevalence and clinical presentation of constipation in children with severe generalized cerebral palsy. Developmental Medicine & Child Neurology. 2010;52(9):e216-e21.
García Contreras AA, Vásquez Garibay EM, Sánchez Ramírez CA, Fafutis Morris M, Delgado Rizo V. Factors associated with the stool characteristics of children with cerebral palsy and chronic constipation. Rev Esp Enfermedades Dig. 2020;112:41-6.
Johanson JF, Sonnenberg A, Koch TR, Mccarty DJ. Association of constipation with neurologic diseases. Digestive diseases and sciences. 1992;37:179-86.
Russo M, Strisciuglio C, Scarpato E, Bruzzese D, Casertano M, Staiano A. Functional chronic constipation: Rome III criteria versus Rome IV criteria. Journal of neurogastroenterology and motility. 2019;25(1):123.
Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, Nurko S. Constipation in infants and children: evaluation and treatment. Journal of pediatric gastroenterology and nutrition. 1999;29(5):612-26.
Biggs WS, Dery WH. Evaluation and treatment of constipation in infants and children. American Family Physician. 2006;73(3):469-77.
Ikee R, Sasaki N, Yasuda T, Fukazawa S. Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet. Microorganisms. 2020;8(12):1862.
Jarzebicka D, Sieczkowska-Golub J, Kierkus J, Czubkowski P, Kowalczuk-Kryston M, Pelc M, et al. PEG 3350 versus lactulose for treatment of functional constipation in children: randomized study. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(3):318-24.
Gheibi S, Imanieh MH, Haghighat M, Niknahad H, Sadegh M, Sayyafan FM, et al. Comparison of the Low Dose Polyethylene Glycol with Lactulose and Magnesium Hydroxide in Constipated Children. A Multicentric Randomized Clinical trial. Life Science Journal. 2012;9(4).
Voskuijl W, De Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004;53(11):1590-4.
Imanieh MH, Golpayegan MR, Sedighi M, Ahmadi K, Aghaie A, Dehghani SM, Yousefi G. Comparison of three therapeutic interventions for chronic constipation in paediatric patients with cerebral palsy: a randomised clinical trial. Gastroenterology Review/Przegląd Gastroenterologiczny. 2019;14(4):292-7.
Loening-Baucke V. Constipation in children. Current Opinion in Pediatrics. 1994;6(5):556-61.
Bishop PR, Nowicki MJ. Defecation disorders in the neurologically impaired child. Pediatric annals. 1999;28(5):322-9.
Marzio L, Del Bianco R, Pieramico O, Cuccurullo F. Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan. American Journal of Gastroenterology (Springer Nature). 1989;84(8).
Staiano A, Del Giudice E, Simeone D, Miele E, Marino A. Cisapride in neurologically impaired children with chronic constipation. Digestive diseases and sciences. 1996;41:870-4.
Cummings J, Branch W, Jenkins D, Southgate D, Houston H, James W. Colonic response to dietary fibre from carrot, cabbage, apple, bran, and guar gum. The Lancet. 1978;311(8054):5-9.
Staiano A, Simeone D, Del Giudice E, Miele E, Tozzi A, Toraldo C. Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children. The Journal of pediatrics. 2000;136(1):41-5.
- Abstract Viewed: 85 times